共 50 条
- [2] Combined Transarterial Chemoembolization (TACE) and Stereotactic Body Radiation Therapy (SBRT) for Management of Primary Hepatocellular Carcinoma (HCC) INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2013, 87 (02): : S319 - S319
- [3] The Treatment Results and Dosimetric Analysis of Stereotactic Body Radiation Therapy (SBRT) With Transarterial Chemoembolization (TACE) for Hepatocellular Carcinoma (HCC) INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2012, 84 (03): : S326 - S326
- [4] Stereotactic Body Radiation Therapy (SBRT) Combined With Transarterial Chemoembolization (TACE) in BCLC Stage B and C Hepatocellular Carcinoma (HCC) INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2016, 96 (02): : E162 - E162
- [5] Stereotactic Body Radiation Therapy (SBRT) Versus Transarterial Chemoembolization (TACE) as a Bridge to Transplant in Unresectable Hepatocellular Carcinoma Annals of Surgical Oncology, 2022, 29 : 33 - 34
- [6] Outcomes of Stereotactic Body Radiotherapy (SBRT) for Hepatocellular Carcinoma (HCC) INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2011, 81 (02): : S70 - S71
- [9] Stereotactic Body Radiation Therapy as an Alternative to Transarterial Chemoembolization for Hepatocellular Carcinoma INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2018, 100 (01): : 122 - 130
- [10] Treatments of transarterial chemoembolization (TACE), stereotactic body radiotherapy (SBRT) and immunotherapy reshape the systemic tumor immune environment (STIE) in patients with unresectable hepatocellular carcinoma JOURNAL OF THE NATIONAL CANCER CENTER, 2025, 5 (01): : 38 - 49